I’ve been stocking up on some Fisher Paykel Healthcare (NZX.FPH) shares over the past few days, so I thought I’d update my pie chart to get a visual representation of my portfolio as it has previously proved useful to me.
The chart isn’t as useful to me as it has previously been because I’m not so fussed about having a balanced portfolio at this stage. This year is mainly about accumulating growth stocks (particularly those growing this year) so I can get as much of a discount as possible to next year’s prices, in preparation of selling up some angel investments to enable my retirement by the end of next financial year.
My case for investing in FPH is because it’s a long term growth stock, which means that even if it falls after proliferation of COVID vaccines, it should recover the position within a few years. However, it’s my believe that this perpetually expensive stock is likely to surprise on the up-side. The reason for this is that the last guidance provided made some conservative assumptions, and the COVID situation has got worse since that guidance was released. Additionally, my research suggests that vaccine deliveries are not happening very quickly when the global population is concerned. I suspect that COVID will be around a long time to come, so FPH is a good bet.
I feel happy to be overweight in FPH and SUM (because of the way the residential property market is going), but am disappointed that I didn’t buy more EBO shares back when I had identified them as good value.